Announcements
Projects
Orgs
Project
Articles 81
Votes 1
0% interested
Targetedonc.com

Authors 48

Conor Killmurray
Alan Bryce
MD
Eleni Efstathiou
Daniel Landau
Adam Weiner
William J. Gradishar
Tony Berberabe
MPH
Jordyn Sava
Naveen Pemmaraju
Ariana Pelosci
Kristie L. Kahl
Cristian Tomasetti
PhD
Aditya Bardia
Nichole Tucker
Targeted Oncology Staff
Lisa Astor
John E. Sylvester
Dylann Cohn-Emery
Luis E. Raez
John M. Burke
Lauren Bollinger
Russ Conroy
Laura Dawson
Kristi Rosa
David O'Malley
Nicholas J. Robert
Bruno Lemos
Jennifer Gass
FACMG
Jonah Feldman
Skye Montoya
Tara Seery
Ritu Salani
Chad A. Hamilton
Pallawi Torka
Crystal Ritchey
Naomi G. Dempsey
Ruchi Garg
Morgan Bayer
Sabrina Serani
Mark A. Davis
MS
Joshua Richter
Nasir Chaudry
Sara A. Hurvitz
Unanswered Questions in the HER2+ Breast Cancer Space - Targeted Oncology
almost2y
Managing HER2+ Early Breast Cancer: A Focus on Target Therapy - Targeted Oncology
almost2y
New Agents and Treatments in Metastatic Prostate Cancer - Targeted Oncology
almost2y
World Neuroendocrine Cancer Awareness Day: Discussing Important Advances in Care - Targeted Oncology
almost2y
Factors Influencing Treatment Post-Chemo in dMMR Endometrial Cancer - Targeted Oncology
almost2y
Liver Cancer Awareness Month: Understanding and Treating HCC - Targeted Oncology
~2y
Using AI to Optimize Therapeutic Choices and QOL in Patients With Cancer - Targeted Oncology
~2y
Diagnostic Approaches for Hematologic Malignancies With Skin Symptoms - Targeted Oncology
~2y
Screening and Vaccination are Key to Prevent Cervical Cancer - Targeted Oncology
~2y
HER2+ Breast Cancer With Brain Metastases Responds to T-DXd - Targeted Oncology
~2y
Discussing the Use of Anti-CD38 Combination Therapy in RRMM - Targeted Oncology
~2y
Maximal Tumor Debulking With Systemic Therapy Does Not Impact QoL in mCRC - Targeted Oncology
~2y
Baptist Health Adopts Innovative AI Solutions, Cutting-Edge Research to Address Complexities of Care - Targeted Oncology
~2y
Proof-of-Concept Study Assesses SSRS for Brain Metastases - Targeted Oncology
~2y
BXCL701 and Pembrolizumab Combo Delivers OS Improvements in SCNC - Targeted Oncology
~2y
T-IELs Could Hold the Key for CRC Immunotherapy - Targeted Oncology
~2y
ESR1 Mutations May Signal Better Results With Oral SERDs in Advanced Breast Cancer - Targeted Oncology
~2y
Defining Earlier Use of Immunotherapy in Patients With NSCLC - Targeted Oncology
~2y
Walking, Strength Building Improves Daily Living in Multiple Myeloma - Cancer Network
~2y
Exploration of PLK1 Inhibition in Advanced Cancers Begins - Targeted Oncology
~2y
Promising Imaging Results Seen With 64Cu SAR-Bombesin in Prostate Cancer - Targeted Oncology
~2y
Leukemia Awareness Month: Biomarker Testing Proves Vital at Every Stage of AML Care - Targeted Oncology
~2y
Molecular Subtyping Leads to New Targeted Trials in Endometrial Cancer - Targeted Oncology
~2y
Fertility and Overtreatment of Premenopausal Breast Cancer - Targeted Oncology
~2y
Risk-Based Treatment of Hodgkin Lymphoma in the Era of Novel Therapies - Targeted Oncology
~2y